Table 2.
| GENE SYMBOL (FEATURE NO.) | INCREASED EXPRESSION LEVEL | P VALUE | PATHWAYS |
|---|---|---|---|
| ABL1 (8019) | poor prognosis | 0.046 | ERBB2, PDGFRB, cell cycle and angiogenesis |
| IGF2R (1723) | poor prognosis | 0.048 | angiogenesis |
| PRKCB1 (6676) | good prognosis | 0.033 | ERBB2 and VEGF |
| MAP2 K4 (18964) | good prognosis | 0.034 | ERBB2 |
| NRG1 (11559) | good prognosis | 0.011 | ERBB2 |
| LYN (19236) | poor prognosis | 0.001 | PDGFRB and angiogenesis |
| STAT3 (4386) | poor prognosis | 0.028 | PDGFRB and angiogenesis |
| STAT3 (15013) | poor prognosis | 0.002 | PDGFRB and angiogenesis |
| VEGFA (1135) | poor prognosis | 0.02 | VEGF and angiogenesis |
| VEGFA (15367) | poor prognosis | 0.008 | VEGF and angiogenesis |
| OIP5 (16433) | poor prognosis | 0.013 | FOXC1 network |
| NCK2 (3851) | poor prognosis | 0.029 | ERBB2 and PDGFRB |
| LDHB (20259) | poor prognosis | 0.038 | Warburg effect |
| GRB2 (16731) | poor prognosis | 0.019 | ERBB2 and PDGFRB |
| *NANOG (C12928.2) | good prognosis | 0.024 | EMT |
| POU5F1 (6057) | good prognosis | 0.02 | EMT |
| GRB2 (1952) | poor prognosis | 0.03 | ERBB2 and PDGFRB |